Xceleron Inc. — Investor Relations & Filings
Filings indexed
11
across all filing types
Latest filing
2003-12-03
Regulatory Filings
Country
CA
Canada
Listing
TSXV
Xceleron Inc. is a specialist provider of ultra-sensitive bioanalytical services crucial for accelerating early drug development. The company pioneered the application of Accelerator Mass Spectrometry (AMS) technology in life sciences, specifically for novel clinical designs, including human microdose and microtracer studies. Xceleron utilizes its expertise to investigate the pharmacokinetics and metabolism of developmental drugs. Key services include micro-dosing, pre-clinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans, enabling predictive clinical research and supporting smarter drug development decisions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2003-12-03 | English | |
| Material change report - English.pdf | 2003-12-02 | English | |
| Material change report - English.pdf | 2002-08-30 | English | |
| Material change report - English.pdf | 2002-08-13 | English | |
| Material change report - English.pdf | 2002-07-25 | English | |
| Material change report - English.PDF | 2001-07-31 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2003
2 filings
| |||||
| 47393690 | Material change report - English.pdf | 2003-12-03 | English | ||
| 47393694 | Material change report - English.pdf | 2003-12-02 | English | ||
|
2002
3 filings
| |||||
| 47393697 | Material change report - English.pdf | 2002-08-30 | English | ||
| 47393730 | Material change report - English.pdf | 2002-08-13 | English | ||
| 47393734 | Material change report - English.pdf | 2002-07-25 | English | ||
|
2001
6 filings
| |||||
| 47393737 | Material change report - English.PDF | 2001-07-31 | English | ||
| 47393897 | Material change report - English.PDF | 2001-07-20 | English | ||
| 47393901 | Final Receipt.pdf | 2001-06-26 | English | ||
| 47393905 | Final prospectus – English.PDF | 2001-06-21 | English | ||
| 47393945 | Preliminary Receipt.pdf | 2001-02-07 | English | ||
| 47393949 | Other.PDF | 2001-02-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Take Solutions Ltd
Provides specialized domain-led technology and services for…
|
TAKE | IN | Professional, scientific and te… |
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
|
Terns Pharmaceuticals, Inc.
Clinical-stage biopharma developing small-molecule drugs fo…
|
TERN | US | Professional, scientific and te… |
|
TERRAGEN HOLDINGS LIMITED
Develops microbial technology to enhance animal health and …
|
TGH | US | Professional, scientific and te… |
Xceleron Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45131/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45131 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45131 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45131 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45131}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xceleron Inc. (id: 45131)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.